Live Breaking News & Updates on Epicentrx Cy

Stay updated with breaking news from Epicentrx cy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

EpicentRx Awarded Funding from FightMND to Evaluate Therapeutic Potential of RRx-001 in Motor Neuron Disease (aka ALS)

/PRNewswire/ EpicentRx Inc. ("EpicentRx"), a late-stage biopharmaceutical company with platforms that treat and target multiple immune-mediated inflammatory. ....

San Diego , United States , Rob Henderson , Epicentrx Cy , Richard Gordon , Tonyr Reid , Pam Mccombe , Translational Research Institute , Queensland University Of Technology , Prnewswire Epicentrx Inc , Centre For Microbiome Research , Michaelj Fox Foundation For Parkinson Research , Associate Professor Richard Gordon , Queensland University , Microbiome Research , Central Nervous System , Royal Brisbane , Professor Pam Mccombe , Chief Executive Officer ,

EpicentRx Announces Presentations Focusing on RRx-001 Inhibition of the NLRP3 Inflammasome at Two Upcoming Scientific Conferences

/PRNewswire/ EpicentRx, a late clinical stage biopharmaceutical company with novel therapies to target cancer and inflammatory diseases, announced it will. ....

United States , San Diego , Prnewswire Epicentrx , Epicentrx Cy , Inflammasome Therapeutics Summit , Control Number , Disease Molecular , Protects Against Inflammasome Driven , Proof Of Concept Trials , Various Disease Groups , Clinical Relevance ,

EpicentRx Awarded Grant from The Michael J. Fox Foundation to Evaluate Therapeutic Potential of RRx-001 in Parkinson's Disease

Press release content from PR Newswire. The AP news staff was not involved in its creation. ....

Shalini Padmanabhan , Richard Gordon , Epicentrx Cy , Tonyr Reid , Australia Foundation , University Of Queensland , Prnewswire Epicentrx Inc , Research Programs , Michaelj Fox Foundation , Epicentrx Inc , Michaelj Fox Foundation For Parkinson Research , Central Nervous System , Chief Executive Officer , Pr Newswire , Parkinson X27s Disease , Michaelj Fox ,

Actinium Pharmaceuticals, Inc. and EpicentRx Announce Strategic Research Collaboration to Combine Targeted Radiotherapies with Next Generation CD47/SIRPα Immunotherapy

/PRNewswire/ Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium" or the "Company"), a leader in the development of targeted radiotherapies for. ....

Astellas Pharma , Epicentrx Cy , Epicentrx Rrx , Tonyr Reid , Sandesh Seth , Hans Vitzthum , Lifesci Advisors , Taft Communications , Society For Immunotherapy Of Cancer , Exchange Commission , Astellas Pharma Inc , Actinium Pharmaceuticals Inc , Epicentrx Inc , Memorial Sloan Kettering Cancer Center , Prnewswire Actinium Pharmaceuticals Inc , San Diego Based , Small Cell Lung Cancer , Annual Society , Antibody Radiation Conjugates , Chief Executive Officer , Actinium Pharmaceuticals , Bone Marrow Transplant , Gene Therapy , Adoptive Cell Therapy , Elderly Relapsed , Refractory Acute Myeloid Leukemia ,

Actinium Pharmaceuticals, Inc. and EpicentRx Announce Strategic Research Collaboration to Combine Targeted Radiotherapies with Next Generation CD47/SIRPα Immunotherapy

/PRNewswire/ Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium" or the "Company"), a leader in the development of targeted radiotherapies for. ....

Astellas Pharma , Epicentrx Cy , Epicentrx Rrx , Tonyr Reid , Sandesh Seth , Hans Vitzthum , Lifesci Advisors , Taft Communications , Society For Immunotherapy Of Cancer , Exchange Commission , Astellas Pharma Inc , Actinium Pharmaceuticals Inc , Epicentrx Inc , Memorial Sloan Kettering Cancer Center , Prnewswire Actinium Pharmaceuticals Inc , San Diego Based , Small Cell Lung Cancer , Annual Society , Antibody Radiation Conjugates , Chief Executive Officer , Actinium Pharmaceuticals , Bone Marrow Transplant , Gene Therapy , Adoptive Cell Therapy , Elderly Relapsed , Refractory Acute Myeloid Leukemia ,